Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2019 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Proteomic analyses of smear-positive/negative tuberculosis patients uncover differential antigen-presenting cell activation and lipid metabolism.
Front Cell Infect Microbiol. 2023 Oct 16;13:1240516. doi: 10.3389/fcimb.2023.1240516. eCollection 2023.
Front Cell Infect Microbiol. 2023.
PMID: 37908762
Free PMC article.
Combining metabolome and clinical indicators with machine learning provides some promising diagnostic markers to precisely detect smear-positive/negative pulmonary tuberculosis.
Hu X, Wang J, Ju Y, Zhang X, Qimanguli W, Li C, Yue L, Tuohetaerbaike B, Li Y, Wen H, Zhang W, Chen C, Yang Y, Wang J, Chen F.
Hu X, et al.
BMC Infect Dis. 2022 Aug 25;22(1):707. doi: 10.1186/s12879-022-07694-8.
BMC Infect Dis. 2022.
PMID: 36008772
Free PMC article.
Item in Clipboard
Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial.
Yuan J, Mo B, Ma Z, Lv Y, Cheng SL, Yang Y, Tong Z, Wu R, Sun S, Cao Z, Wu J, Zhu D, Chang L, Zhang Y; Investigator Group of the Phase 3 Study on Oral Nemonoxacin.
Yuan J, et al.
J Microbiol Immunol Infect. 2019 Feb;52(1):35-44. doi: 10.1016/j.jmii.2017.07.011. Epub 2017 Aug 2.
J Microbiol Immunol Infect. 2019.
PMID: 30181096
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite